Pictet Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-271,426
Closed -$20.5M 2171
2026
Q1
$20.5M Sell
271,426
-60,343
-18% -$4.54M 0.02% 493
2025
Q4
$24.7M Buy
331,769
+173,749
+110% +$12.7M 0.02% 479
2025
Q3
$10.7M Sell
158,020
-12,514
-7% -$831K 0.01% 661
2025
Q2
$11.1M Sell
170,534
-61,559
-27% -$3.69M 0.01% 631
2025
Q1
$14.3M Sell
232,093
-74,056
-24% -$4.91M 0.02% 570
2024
Q4
$22.1M Sell
306,149
-21,539
-7% -$1.68M 0.02% 476
2024
Q3
$26.7M Buy
327,688
+6,914
+2% +$553K 0.03% 414
2024
Q2
$23.8M Sell
320,774
-6,068
-2% -$455K 0.03% 427
2024
Q1
$25.5M Buy
326,842
+1,853
+0.6% +$138K 0.03% 435
2023
Q4
$23.2M Sell
324,989
-31,959
-9% -$2.23M 0.03% 449
2023
Q3
$24.8M Buy
+356,948
New +$27M 0.03% 409

Other funds holding HOLX

Pictet Asset Management's HOLX Position: Q2 2026 in Review

Pictet Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 271,426 shares — an estimated $20.5M sold.

Pictet Asset Management first reported a position in HOLX in Q3 2023 and held it in 11 quarters. The position peaked at $26.7M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Pictet Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Pictet Asset Management sold 271,426 Hologic shares in Q2 2026, an estimated $20.5M.
  • Pictet Asset Management first reported a position in Hologic in Q3 2023 and held it in 11 quarters.
  • Pictet Asset Management's Hologic position peaked at $26.7M in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.